Tuesday, February 12, 2008

The spread of bird flu




Latest Medical News For Bird Flu / Avian Flu

FluForecast(R) Replikin Count(TM) Predicts That The H5N1 Cycle Which Began In 1996 Is Now Over
12 Feb 2008

Information Session For Owners Of Small Flocks And Pet Birds, Canada
04 Feb 2008

Bird Flu Affects Half Of Bangladesh Districts
03 Feb 2008

Influenza Virus In Norway Resistant Against Oseltamivir (Tamiflu(R))
03 Feb 2008

Information Session For Owners Of Small Flocks And Pet Birds, Canada
31 Jan 2008

New Vaccine Against Deadliest Strain Of Avian Flu Tested By University Of Pittsburgh Scientists
30 Jan 2008

Government Helps Protect Backyard Birds From Avian Influenza
29 Jan 2008

PuriCore's Sterilox Solution Highly Effective Against Pandemic H5N1 Avian Influenza
28 Jan 2008

Sixth Swan Tests Positive For H5N1 Bird Flu Virus Strain, England
26 Jan 2008

NanoViricides Is On Course To Develop Bird Flu, Influenza, And Other Drugs
25 Jan 2008

New Avian Influenza Flare-Ups
25 Jan 2008

eFoodSafety To Attend International Conference On Avian Influenza
24 Jan 2008

The Aethlon Hemopurifier(R) Proves Effective In Capturing Bird Flu Virus
23 Jan 2008

India Bird Flu Cull Hampered
18 Jan 2008

GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
16 Jan 2008

Juvaris BioTherapeutics Announces Cooperative Research And Development Agreement With The Centers For Disease Control And Prevention
16 Jan 2008

Indonesian Woman Dies Of Bird Flu, Total Is 95
14 Jan 2008

Confirmed H5N1 Avian Influenza In Wild Swans In Dorset, UK
11 Jan 2008

Avian Influenza - Still A Disease Of Birds, UK
11 Jan 2008

Mute Swans Infected With Bird Flu In Dorset, England
10 Jan 2008

Avian Flu and Humans

The disease is transmittable to humans by direct or indirect contact with infected birds, mammals (?) and poultry. Till date there have been no recorded instances of transmission of the disease between infected wild birds and humans, and most human cases have been associated with close contact with infected domestic poultry. The risk of a human contracting the disease from a wild bird is remote and , perhaps, hypothetical at present.

There is no hard evidence of human-to-human transmission till date and currently the H5N1 virus strain is not considered to be contagious between humans.

Avian flu first 'jumped' the "species barrier" from birds to humans and caused an outbreak in Hong Kong in 1997. Humans may be infected via close contact with infected birds and by working in an environment that is heavily contaminated with HPAI viruses. You can catch the virus if an infected bird coughs or sneezes directly in your face or if you breathe in particles from the droppings (wind-borne dry dropping particles are a source). Infection has not been transmitted via handling or consumption of poultry products (meat and eggs)[15]. Recent developments, however, point at instances of possible transmission of H5N1 viruses through consumption of uncooked duck blood. Therefore, uncooked poultry or poultry products, including blood, should not be consumed.

Influenza viruses are RNA viruses, meaning they lack mechanisms for proofreading and repairing genetic errors. This makes them especially prone to mutation requiring us to reformulate vaccines every year.

Signs and symptoms: Since H5N1 is an influenza virus, symptoms similar to those of the common flu, such as fever, malaise, cough, sore throat, and sore muscles, can develop in infected humans. However, in some cases, pneumonia and severe problems with the respiratory system can develop. Patients with H5N1 avian influenza have rarely had conjunctivitis, unlike human cases of the H7 virus. Persistent high fever is an useful symptom.

Diagnosis: X-ray of the chest is useful in detecting early viral pneumonia.
Treatment: Treatment for infection by the H5N1 strain is essentially similar to that employed for infections due to the other influenza viruses. Four Antivirals work against influenza. Amantadine and Rimantadine (which target M2, a proton channel found in the viral membrane) have minimal efficacy against H5N1. Both Tamiflu (marketed by Roche), known generically as oseltamivir, and Relenza, known generically as zanamivir (marketed by GlaxoSmithKline), work better. Tamiflu and Relenza, in a class known as neuraminidase inhibitors (which act on a protein conserved in all influenza A viruses), do not cure influenza infection but can reduce the severity of illness, by attacking the influenza virus and stopping it from spreading, if given within 48 hours after symptoms begin. They may also help prevent infection if given early

The expensive and not readily available Tamiflu (a full course of Tamiflu -10 pills over five days, costs USD 80 - 90) has become the brand of choice for governments and organizations in their preparations for a possible H5N1 pandemic. Amantadine and rimantadine are inexpensive and widely available. The current strain of H5N1 found in Northern China, Mongolia, Kazakhstan and Russia is not Amantadine resistant

The flu vaccine currently in use worldwide protects against different strains of the human flu virus, but offers little protection from bird flu. In August 2005, scientists said they have successfully tested in people a vaccine that they believe can protect against the strain of avian influenza but it may not be readily available in time before a pandemic starts.